Ohio Public Employees Retirement System (OPERS)’s TScan Therapeutics TCRX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio TCRX Stock Details TCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28K	Buy	+27,700	New	+$29.6K	﹤0.01%	2112

Other funds holding TCRX

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s TCRX Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) opened a new position in TScan Therapeutics (TCRX) in Q1 2026: 27,700 shares worth $28K. The stake represents ﹤0.01% of the portfolio and ranks #2112 among its holdings.

60 funds tracked by Wall St. Rank hold TCRX as of Q1 2026.

Ohio Public Employees Retirement System (OPERS) held 27,700 shares of TScan Therapeutics worth $28K as of Q1 2026.
TScan Therapeutics was a new Ohio Public Employees Retirement System (OPERS) position in Q1 2026.
TScan Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #2112 holding.
60 funds tracked by Wall St. Rank held TScan Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.